Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$2.87M Sell
10,124
-250
-2% -$75.4K 1.22% 26
2018
Q3
$3.31M Sell
10,374
-52
-0.5% -$16.6K 1.19% 31
2018
Q2
$3.35M Sell
10,426
-476
-4% -$149K 1.22% 27
2018
Q1
$2.98M Buy
10,902
+460
+4% +$122K 1.08% 32
2017
Q4
$2.54M Buy
10,442
+1,174
+13% +$267K 1.13% 37
2017
Q3
$1.87M Buy
9,268
+387
+4% +$76.1K 0.99% 41
2017
Q2
$1.82M Sell
8,881
-92
-1% -$18.3K 1.03% 38
2017
Q1
$1.64M Sell
8,973
-583
-6% -$102K 0.97% 39
2016
Q4
$1.53M Buy
9,556
+400
+4% +$58.8K 0.97% 48
2016
Q3
$1.29M Sell
9,156
-7,724
-46% -$1.08M 0.9% 54
2016
Q2
$2.3M Buy
16,880
+8,900
+112% +$1.18M 0.79% 55
2016
Q1
$1.08M Buy
7,980
+2,839
+55% +$384K 0.85% 50
2015
Q4
$770K Buy
+5,141
New +$760K 0.7% 72

Other funds holding CHE

Palo Capital's CHE Position: Q4 2018 in Review

Palo Capital reduced its Chemed (CHE) stake by 2.4% in Q4 2018, selling an estimated $75.4K and leaving 10,124 shares worth $2.87M. The position accounts for 1.22% of the portfolio, ranked #26.

Palo Capital first reported a position in CHE in Q4 2015 and has held it in 13 quarters since. The position peaked at $3.35M in Q2 2018. 359 funds tracked by Wall St. Rank hold CHE as of Q4 2018.

  • Palo Capital held 10,124 shares of Chemed worth $2.87M as of Q4 2018.
  • Palo Capital sold 250 Chemed shares in Q4 2018, an estimated $75.4K.
  • Chemed made up 1.22% of Palo Capital's portfolio in Q4 2018, its #26 holding.
  • Palo Capital first reported a position in Chemed in Q4 2015 and has held it in 13 quarters since.
  • Palo Capital's Chemed position peaked at $3.35M in Q2 2018.
  • 359 funds tracked by Wall St. Rank held Chemed as of Q4 2018.

Based on Palo Capital's 13F filing for Q4 2018, filed 30 Jan 2019.